362 related articles for article (PubMed ID: 33328740)
21. A new and rare type of hepatocellular carcinoma: Survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma.
Guo WX; Yang SY; Guo L; Feng JK; Xue J; Shi J; Lau WY; Yu D; Cheng SQ
Pathol Res Pract; 2023 Jan; 241():154260. PubMed ID: 36509007
[TBL] [Abstract][Full Text] [Related]
22. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation combined with apatinib and camrelizumab in patients with advanced hepatocellular carcinoma: A single-arm, preliminary study.
Li X; Zhang Q; Lu Q; Cheng Z; Liu F; Han Z; Yu X; Yu J; Liang P
Front Immunol; 2022; 13():1023983. PubMed ID: 36389778
[TBL] [Abstract][Full Text] [Related]
24. Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Li J; Quan B; Liu W; Zhao M; Yao F; Chen R; Ren Z; Yin X
Ther Adv Med Oncol; 2024; 16():17588359241231252. PubMed ID: 38617024
[TBL] [Abstract][Full Text] [Related]
25. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension.
Qiu Z; Wang G; Yan H; Qi H; Zuo M; Wang G; Jiang W; Chen Z; Xue J; Lu L; Zhang F; Gao F
Eur Radiol; 2022 Oct; 32(10):6777-6787. PubMed ID: 35441840
[TBL] [Abstract][Full Text] [Related]
26. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis.
Zhang ZH; Hou SN; Yu JZ; Zhang W; Ma JQ; Yang MJ; Liu QX; Liu LX; Luo JJ; Qu XD; Yan ZP
Front Oncol; 2022; 12():1086095. PubMed ID: 36741718
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
Ou X; Wu J; Wu J; Fu Y; Zeng Z; Li S; Li Y; Liu D; Li H; Li B; Zhou J; Zhuang S; Cheng S; Zhang Z; Wang K; Qu S; Yan M
Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38697847
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
29. Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study.
Huang Y; Zhang Z; Liao W; Hu K; Wang Z
Front Oncol; 2021; 11():650394. PubMed ID: 34408974
[TBL] [Abstract][Full Text] [Related]
30. Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience.
Patidar Y; ; Mukund A; Sarin SK
Indian J Radiol Imaging; 2021 Apr; 31(2):270-276. PubMed ID: 34556907
[No Abstract] [Full Text] [Related]
31. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis.
Li XL; Guo WX; Hong XD; Yang L; Wang K; Shi J; Li N; Wu MC; Cheng SQ
Hepatol Res; 2016 Oct; 46(11):1088-1098. PubMed ID: 26783741
[TBL] [Abstract][Full Text] [Related]
33. Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE,
Zhao XH; Li HL; Guo CY; Yao QJ; Xia WL; Hu HT
J Hepatocell Carcinoma; 2023; 10():231-240. PubMed ID: 36819987
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of apatinib combined with transarterial chemoembolization for hepatocellular carcinoma with portal venous tumor thrombus: a retrospective study.
Liu C; Xing W; Si T; Yu H; Guo Z
Oncotarget; 2017 Nov; 8(59):100734-100745. PubMed ID: 29246017
[TBL] [Abstract][Full Text] [Related]
35. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
Yang Z; Zou R; Zheng Y; Qiu J; Shen J; Liao Y; Zhang Y; Wang C; Wang Y; Yuan Y; Li K; Zuo D; He W; Liu W; Li B; Yuan Y
Eur Radiol; 2019 Nov; 29(11):5752-5762. PubMed ID: 30993438
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Shi J; Lai EC; Li N; Guo WX; Xue J; Lau WY; Wu MC; Cheng SQ
Ann Surg Oncol; 2010 Aug; 17(8):2073-80. PubMed ID: 20131013
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes of deceased donor liver transplantation in hepatocellular carcinoma patients with portal vein tumor thrombus: A multicenter study.
Yu J; Zhuang L; Liu P; Liu Z; Ling S; Deng Y; Li J; Yang B; Chen Z; Wang Z; Zang Y; Yang Y; Zheng S; Xu X
Eur J Surg Oncol; 2022 Jan; 48(1):121-132. PubMed ID: 34456082
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.
Feng JK; Liu ZH; Fu ZG; Chai ZT; Sun JX; Wang K; Cheng YQ; Zhu HF; Xiang YJ; Zhou LP; Shi J; Guo WX; Zhai J; Cheng SQ
Front Oncol; 2022; 12():954203. PubMed ID: 36505818
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
40. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma.
Li Z; Chen Q; Zhang W; Si G; Li J; Jiao D; Han X
Can J Gastroenterol Hepatol; 2021; 2021():5565793. PubMed ID: 34458205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
